期刊文献+

VEGF-C及其受体Flt-4在肺鳞状细胞癌中的表达及其与淋巴结转移的关系 被引量:1

Expression and clinical significance of VEGF-C and Flt-4 in squamous cell of lung cancer and the relation with the lymphnode metastasis
下载PDF
导出
摘要 目的探讨VEGF-C及其受体Flt-4在肺鳞状细胞癌中的表达及其与淋巴结转移的关系。方法采用免疫组化S-P法检测89例肺鳞状细胞癌原发灶组织、癌旁组织中VEGF-C、Flt-4的表达,并分析其与临床病理特征的关系。结果 (1)VEGF-C和Flt-4在癌组织中和转移的淋巴结转移组中高表达(P<0.05);(2)在肺鳞状细胞癌组织中VEGF-C、Flt-4的表达与分化程度相关(P<0.05),VEGF-C和Flt-4与吸烟指数相关(P<0.05),VEGF-C的表达与淋巴结转移呈正相关(P<0.05),与TNM分期相关(P<0.05);(3)VEGF-C与Flt-4在肺鳞状细胞癌细胞中的表达呈正相关(r=0.372,P<0.05)。结论 VEGF-C与Flt-4受体在肺鳞状细胞癌中高表达与淋巴结转移呈正相关。 Objective To study the protein expression and clinical significance of VEGF-C and Flt-4 in squamous cell of lung cancer and the relation with the lymph node metastasis.MethodsVEGF-C and Flt-4 expression were evaluated in the primary and adjacent normal tissues of 89 patients with squamous cell of lung cancer as well as lymphnode metastasis tissues of 41 patients by immunohistoehemistry(S-P method).And analyse th relation to the clinic pathology.ResultsPositive expression rate of VEGF-C and Flt-4 in squamous cell of lung cancer and lymphnode metastasis tissues were higher than of normal tissues(P0.05).There was correlation between the expression of VEGF-C and Flt-4 protein and histopathologic classification,smoking exponent(P0.05).There was correlation between the expression of VEGF-C and TNM(P0.05).The rate of lymphnode metastasis in high-expression group of 41 patients was higher than those in low-expression group(P0.05).There was positive correlation between the expression of VEGF-C and Flt-4 in squamous cell of lung cancer(r=0.372,P0.05).ConclusionThere was significantly correlation between the expression of VEGF-C and Flt-4 in squamous cell of lung cancer and lymphnode metastasis.
出处 《新疆医科大学学报》 CAS 2011年第8期812-816,共5页 Journal of Xinjiang Medical University
基金 新疆医科大学科技创新基金(2009-26)
关键词 肺鳞状细胞癌 VEGF-C FLT-4 淋巴结转移 squamous cell of lung cancer vascular endothelial growth factor c vascular endothelial growth factor receptor-4 lymphnode metastasis
  • 相关文献

参考文献9

二级参考文献89

共引文献63

同被引文献28

  • 1Kasai T, Motoori K, Horikoshi T, et al. Dual-time point scantling of integrated FDG PET/CT for the evalaation off mediastinal and hilar lymph nodes in non-small cell lung cancer diagnosed as operable by contrast-enhanced CT[J]. Eur J Radiol, 2010, 75:143-146.
  • 2Yang W, Fu Z, Yu J, et al. Value of PET/CT versus enhanced CT for locoregional lymph nodes in non-small cell lung cancer[J]. Lung Can- cer, 2008, 61:35-43.
  • 3Wang Z, Shi Q, Wang Z M, et al. Clinicopathologic correlation ofcancer stem cell markers CIM4,CD24,VEGF and HIF-lainductal carcinoma in situ and invasive ductal carcinoma of breast: an immunohistochem- istry-based pilot study[J]. Pathol Res Pratt, 2011,207(8):505-513.
  • 4Feng Y, Wang W, Hu J, et al. Expression of VEGF-C and VE (,F-D as significant markers tbr assessment of lymphangiogenesis and lymph node metastasis in non-small cell lung cancer[J]. Anat Rec (Hoboken), 2010, 293:802-812.
  • 5De Cabanyes Candela S, Detterbecrk FC. A systematic review of restaging after induction therapy for stage Ⅲ a lung c.aneer: predittion ofpathnlogie slage[J]. J Thurac Oncol, 2010, 5:389-398.
  • 6Albain KS, Swarm RS, Ruseh VW, et al. Radiotherapy plus :hemothempy with or without surgical resection for stage non-small-cell lung cancer: a phase m randomised controlled trial [J]. Lancet, 2009, 374:379-386.
  • 7Eyal S, Shiran S, Diana K, et al. Unraveling novel mechanisms by which the CD24 oncogene serves as a target for colorectal and pan- creatic cancer treatment,via down-regulation by monoclonal antibod- ies or SIRNA[J]. AGA Abstract, 2008:134 A-149.
  • 8Palma D, Visser O, Lagevaard F J, et al. Treatment of stage I NSCLC in elderly patients: a population-based matched-pair comparison of stereotactic radiotherapy versus surgery [J]. Radiother Oneol, 2011, 101:240-244.
  • 9Ebihara A, Nomori H, Watanabe K, et al. Characteristics of advan- tages of positron emission tomography over computed tomography for N-staging in lung cancer patients [J]. Jpn J Clin Oncol, 2006,36 (1 1):694-698.
  • 10Fang Y, Hu J, Ma J, et al. RNAi-mediated silencing of VEGF-C inhi- bits non-small cell lung cancer progression by simultaneously down-regulating the CXCR4,CCR7,EGFR-2 and VEGFR-3-depen- dent axes-induced ERK,p38 and AKT signalling pathways [J]. Eur J Cancer, 2011,47(15): 2353-2363.

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部